Change in auditor
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)
CHANGE IN AUDITOR
Shareholders are referred to the announcement released on 20 March 2023 whereby shareholders
were advised of the termination of the services of our auditors with effect from 17 March 2023.
Shareholders are hereby advised, in compliance with paragraph 3.78 of the Listings Requirements of
the JSE Limited, that the board of directors of the Company (“Board”) has appointed Nexia SAB&T as
its new external auditors, with Johandré Engelbrecht as designated audit partner, with effect from today,
6 April 2023.
Given the reduction in size and complexity of the Company, the Board is of the view that Nexia SAB&T
will best suit its needs going forward. The appointment is aligned with various ongoing cost optimisation
initiatives in the Company and will result in a material saving in audit and advisory costs going forward.
Shareholders will be requested to approve the appointment at the Company’s next annual general
meeting, details of which will be communicated to shareholders in due course.
The Company looks forward to working with Nexia SAB&T.
Johannesburg
6 April 2023
Sponsor
Valeo Capital (Pty) Ltd
1
Date: 06-04-2023 04:51:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.